400 related articles for article (PubMed ID: 34098555)
1. COVID-19 in CKD Patients: Lessons from 553 CKD Patients with Biopsy-Proven Kidney Disease.
Román JL; García-Carro C; Agraz I; Toapanta N; Vergara A; Gabaldón A; Torres I; Bury R; Baldallo C; Serón D; Soler MJ
Kidney Blood Press Res; 2021; 46(4):452-459. PubMed ID: 34098555
[TBL] [Abstract][Full Text] [Related]
2. Association between Chronic Kidney Disease or Acute Kidney Injury and Clinical Outcomes in COVID-19 Patients.
Kang SH; Kim SW; Kim AY; Cho KH; Park JW; Do JY
J Korean Med Sci; 2020 Dec; 35(50):e434. PubMed ID: 33372426
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
5. High hemoglobin is associated with increased in-hospital death in patients with chronic obstructive pulmonary disease and chronic kidney disease: a retrospective multicenter population-based study.
Xu L; Chen Y; Xie Z; He Q; Chen S; Wang W; Liu G; Liao Y; Lu C; Hao L; Sun J; Shi W; Liang X;
BMC Pulm Med; 2019 Sep; 19(1):174. PubMed ID: 31533673
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and chronic renal disease: clinical characteristics and prognosis.
Yang D; Xiao Y; Chen J; Chen Y; Luo P; Liu Q; Yang C; Xiong M; Zhang Y; Liu X; Chen H; Deng A; Huang K; Cheng B; Peng A
QJM; 2020 Nov; 113(11):799-805. PubMed ID: 32840579
[TBL] [Abstract][Full Text] [Related]
7. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey.
Ozturk S; Turgutalp K; Arici M; Odabas AR; Altiparmak MR; Aydin Z; Cebeci E; Basturk T; Soypacaci Z; Sahin G; Elif Ozler T; Kara E; Dheir H; Eren N; Suleymanlar G; Islam M; Ogutmen MB; Sengul E; Ayar Y; Dolarslan ME; Bakirdogen S; Safak S; Gungor O; Sahin I; Mentese IB; Merhametsiz O; Oguz EG; Genek DG; Alpay N; Aktas N; Duranay M; Alagoz S; Colak H; Adibelli Z; Pembegul I; Hur E; Azak A; Taymez DG; Tatar E; Kazancioglu R; Oruc A; Yuksel E; Onan E; Turkmen K; Hasbal NB; Gurel A; Yelken B; Sahutoglu T; Gok M; Seyahi N; Sevinc M; Ozkurt S; Sipahi S; Bek SG; Bora F; Demirelli B; Oto OA; Altunoren O; Tuglular SZ; Demir ME; Ayli MD; Huddam B; Tanrisev M; Bozaci I; Gursu M; Bakar B; Tokgoz B; Tonbul HZ; Yildiz A; Sezer S; Ates K
Nephrol Dial Transplant; 2020 Dec; 35(12):2083-2095. PubMed ID: 33275763
[TBL] [Abstract][Full Text] [Related]
8. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
[TBL] [Abstract][Full Text] [Related]
9. Association between chronic kidney disease and COVID-19-related mortality in New York.
Mohamed NE; Benn EKT; Astha V; Okhawere KE; Korn TG; Nkemdirim W; Rambhia A; Ige OA; Funchess H; Mihalopoulos M; Meilika KN; Kyprianou N; Badani KK
World J Urol; 2021 Aug; 39(8):2987-2993. PubMed ID: 33481113
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
[TBL] [Abstract][Full Text] [Related]
11. Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients.
Chen C; Wang F; Chen P; Jiang J; Cui G; Zhou N; Moroni F; Moslehi JJ; Ammirati E; Wang DW
J Am Heart Assoc; 2020 Nov; 9(21):e017736. PubMed ID: 32807002
[TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease linked to SARS-CoV-2 infection: a case report.
Tarris G; de Rougemont A; Estienney MA; Journet J; Lariotte AC; Aubignat D; Rebibou JM; De La Vega MF; Legendre M; Belliot G; Martin L
BMC Nephrol; 2021 Aug; 22(1):278. PubMed ID: 34376184
[TBL] [Abstract][Full Text] [Related]
13. Determinants of healing among patients with coronavirus disease 2019: the results of the SARS-RAS study of the Italian Society of Hypertension.
Mancusi C; Grassi G; Borghi C; Carugo S; Fallo F; Ferri C; Giannattasio C; Grassi D; Letizia C; Minuz P; Muiesan ML; Perlini S; Pucci G; Rizzoni D; Salvetti M; Sarzani R; Sechi L; Veglio F; Volpe M; Iaccarino G;
J Hypertens; 2021 Feb; 39(2):376-380. PubMed ID: 33186327
[TBL] [Abstract][Full Text] [Related]
14. Coronavirus Disease 2019 and Chronic Kidney Disease - A Clinical Observational Study.
Shankar M; Narasimhappa S; MuddeGowda MK; Siddappa MN; Ramprasad K; Lingaraj U
Saudi J Kidney Dis Transpl; 2021; 32(3):744-753. PubMed ID: 35102917
[TBL] [Abstract][Full Text] [Related]
15. Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease.
Pilgram L; Eberwein L; Wille K; Koehler FC; Stecher M; Rieg S; Kielstein JT; Jakob CEM; Rüthrich M; Burst V; Prasser F; Borgmann S; Müller RU; Lanznaster J; Isberner N; Tometten L; Dolff S;
Infection; 2021 Aug; 49(4):725-737. PubMed ID: 33851328
[TBL] [Abstract][Full Text] [Related]
16. Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.
Iaccarino G; Grassi G; Borghi C; Ferri C; Salvetti M; Volpe M;
Hypertension; 2020 Aug; 76(2):366-372. PubMed ID: 32564693
[TBL] [Abstract][Full Text] [Related]
17. Community- versus hospital-acquired acute kidney injury in hospitalised COVID-19 patients.
Bell JS; James BD; Al-Chalabi S; Sykes L; Kalra PA; Green D
BMC Nephrol; 2021 Jul; 22(1):269. PubMed ID: 34301204
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Course and Prognostic Factors of COVID-19 in Patients with Chronic Kidney Disease, A Study in Six Centers.
Najafi N; Akbari R; Lotfi Z; Makhough A; Vahedi M; Asgharpour M; Ghorban Sabagh M; Marghoob B; Mirzaei Ilali N; Saddadi F; Shams Z; Ossareh S
Iran J Kidney Dis; 2021 Jul; 15(4):279-287. PubMed ID: 34278999
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular outcomes in patients with chronic kidney disease and COVID-19: a multi-regional data-linkage study.
Lambourg EJ; Gallacher PJ; Hunter RW; Siddiqui M; Miller-Hodges E; Chalmers JD; Pugh D; Dhaun N; Bell S
Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35551093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
